CA3125695A1 - Method for evaluating molecular changes related to a molecule effect in a biological sample - Google Patents

Method for evaluating molecular changes related to a molecule effect in a biological sample Download PDF

Info

Publication number
CA3125695A1
CA3125695A1 CA3125695A CA3125695A CA3125695A1 CA 3125695 A1 CA3125695 A1 CA 3125695A1 CA 3125695 A CA3125695 A CA 3125695A CA 3125695 A CA3125695 A CA 3125695A CA 3125695 A1 CA3125695 A1 CA 3125695A1
Authority
CA
Canada
Prior art keywords
interest
biological sample
molecule
roi
dosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3125695A
Other languages
English (en)
French (fr)
Inventor
Jonathan STAUBER
Rima AIT-BELKACEM
David BONNEL
Fabien PAMELARD
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imabiotech
Original Assignee
Imabiotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imabiotech filed Critical Imabiotech
Publication of CA3125695A1 publication Critical patent/CA3125695A1/en
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00—Image analysis
    • G06T7/0002—Inspection of images, e.g. flaw detection
    • G06T7/0012—Biomedical image inspection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/10—Image acquisition modality
    • G06T2207/10004—Still image; Photographic image
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/30—Subject of image; Context of image processing
    • G06T2207/30004—Biomedical image processing
    • G06T2207/30096—Tumor; Lesion

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Theoretical Computer Science (AREA)
  • Radiology & Medical Imaging (AREA)
  • Quality & Reliability (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA3125695A 2019-01-22 2020-01-21 Method for evaluating molecular changes related to a molecule effect in a biological sample Pending CA3125695A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19305081 2019-01-22
EP19305081.2 2019-01-22
PCT/EP2020/051388 WO2020152151A1 (en) 2019-01-22 2020-01-21 Method for evaluating molecular changes related to a molecule effect in a biological sample

Publications (1)

Publication Number Publication Date
CA3125695A1 true CA3125695A1 (en) 2020-07-30

Family

ID=65494061

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3125695A Pending CA3125695A1 (en) 2019-01-22 2020-01-21 Method for evaluating molecular changes related to a molecule effect in a biological sample

Country Status (6)

Country Link
US (1) US20220137027A1 (enExample)
EP (1) EP3914911A1 (enExample)
JP (1) JP2022517827A (enExample)
CN (1) CN113330312B (enExample)
CA (1) CA3125695A1 (enExample)
WO (1) WO2020152151A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115541692A (zh) * 2022-10-20 2022-12-30 中国科学院兰州化学物理研究所 一种同时分析小扁豆萌发过程中多种脂类成分空间分布变化的质谱成像方法
WO2024185286A1 (ja) * 2023-03-07 2024-09-12 株式会社島津製作所 イメージング質量分析を用いた解析方法
CN117740919A (zh) * 2023-11-27 2024-03-22 中国科学院深圳先进技术研究院 一种肿瘤类器官空间成像表征方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8229194B2 (en) * 2006-11-16 2012-07-24 Visiopharm A/S Feature-based registration of sectional images
AU2009258038A1 (en) * 2008-03-14 2009-12-17 Eastern Virginia Medical School Imaging mass spectrometry for improved prostate cancer diagnostics
CN101975818B (zh) * 2010-04-29 2012-12-26 中国计量科学研究院 特征物质的检测系统及方法
FR2973112B1 (fr) * 2011-03-21 2018-05-25 Imabiotech Procede de detection et de quantification d'une molecule cible dans un echantillon
US20150262329A1 (en) * 2012-10-03 2015-09-17 KONINKLIJKE PHILIPS N.V. a corporation Combined sample examinations
WO2014078374A2 (en) * 2012-11-13 2014-05-22 Presage Biosciences, Inc. Methods for multiplexed drug evaluation
CA2899994C (en) * 2013-02-25 2022-08-30 Imabiotech Method to evaluate the tissue targeting of a molecule of interest
CA2947650C (en) * 2014-05-29 2021-04-27 Spring Bioscience Corporation Anti- indoleamine 2,3-dioxygenase 1 antibodies and diagnostic uses thereof
GB201413162D0 (en) * 2014-07-24 2014-09-10 Immusmol Sas Prediction of cancer treatment based on determination of enzymes or metabolites of the kynurenine pathway
FR3025317B1 (fr) * 2014-08-26 2022-09-23 Imabiotech Methode de caracterisation d'un echantillon par imagerie par spectrometrie de masse
CA3182538C (en) * 2015-06-11 2026-05-26 University Of Pittsburgh - Of The Commonwealth System Of Higher Educatio Systems and methods for finding regions of interest in hematoxylin and eosin (h&e) stained tissue images and quantifying intratumor cellular spatial heterogeneity in multiplexed/hyperplexed fluorescence tissue images
WO2017049403A1 (en) * 2015-09-22 2017-03-30 University Health Network System and method for optimized mass spectrometry analysis
US10609324B2 (en) * 2016-07-18 2020-03-31 Snap Inc. Real time painting of a video stream
CN107424156B (zh) * 2017-06-28 2019-12-06 北京航空航天大学 基于仿仓鸮眼视觉注意的无人机自主编队精准测量方法

Also Published As

Publication number Publication date
US20220137027A1 (en) 2022-05-05
WO2020152151A1 (en) 2020-07-30
CN113330312A (zh) 2021-08-31
JP2022517827A (ja) 2022-03-10
EP3914911A1 (en) 2021-12-01
CN113330312B (zh) 2025-03-21

Similar Documents

Publication Publication Date Title
Zhang et al. Mass spectrometry-based metabolomics in health and medical science: a systematic review
Aichler et al. MALDI Imaging mass spectrometry: current frontiers and perspectives in pathology research and practice
Ly et al. High-mass-resolution MALDI mass spectrometry imaging of metabolites from formalin-fixed paraffin-embedded tissue
Chaurand et al. Molecular imaging of thin mammalian tissue sections by mass spectrometry
Walch et al. MALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histology
Franck et al. MALDI imaging mass spectrometry: state of the art technology in clinical proteomics
Prideaux et al. Mass spectrometry imaging of levofloxacin distribution in TB-infected pulmonary lesions by MALDI-MSI and continuous liquid microjunction surface sampling
Sun et al. Qualitative and quantitative mass spectrometry imaging of drugs and metabolites in tissue at therapeutic levels
Herring et al. Direct tissue analysis by matrix-assisted laser desorption ionization mass spectrometry: application to kidney biology
Nilsson et al. In situ mass spectrometry imaging and ex vivo characterization of renal crystalline deposits induced in multiple preclinical drug toxicology studies
Gorman et al. Mass spectrometry imaging of metals in tissues and cells: Methods and biological applications
JP2002537561A (ja) 細胞タンパク質成分を単離および分析するための方法および装置
Neubert et al. Current frontiers in clinical research application of MALDI imaging mass spectrometry
US20220137027A1 (en) Method for evaluating molecular changes related to a molecule effect in a biological sample
Végvári et al. Localization of tamoxifen in human breast cancer tumors by MALDI mass spectrometry imaging
Timerbaev Application of ICP-MS to the development of metal-based drugs and diagnostic agents: where do we stand?
CA2871736A1 (en) Quantitation of biomarkers for the detection of prostate cancer
Chen et al. Targeting amine-and phenol-containing metabolites in urine by dansylation isotope labeling and liquid chromatography mass spectrometry for evaluation of bladder cancer biomarkers
Poncelet et al. Target exposure and pharmacodynamics study of the indoleamine 2, 3-dioxygenase-1 (IDO-1) inhibitor epacadostat in the CT26 mouse tumor model
Turker et al. MALDI-MS of drugs: Profiling, imaging, and steps towards quantitative analysis
Patel et al. MALDI-MS imaging for the study of tissue pharmacodynamics and toxicodynamics
Downes et al. Application of proteomic strategies to the identification of urinary biomarkers for prostate cancer: a review
Timms et al. Advances in mass spectrometry-based cancer research and analysis: from cancer proteomics to clinical diagnostics
JP2022517827A5 (enExample)
Manzanares-Meza et al. MALDI imaging: beyond classic diagnosis

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20231229

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD

Year of fee payment: 5

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250114

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250114

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250114

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20250115

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20250514

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250515

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20250722

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20250722

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 6TH ANNIV.) - STANDARD

Year of fee payment: 6

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20251223

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20251223

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20260319

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20260714

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20260723